Medical Diagnostic Credential Authority Failure Through Litigation-Driven Mass Screening Operations in Asbestos Tort Claims

Asbestos litigation became the largest mass tort in American legal history, generating hundreds of thousands of claims against manufacturers, distributors, and employers. Filing a claim required a medical diagnosis of an asbestos-related condition. To generate plaintiffs, law firms contracted with mobile X-ray screening companies that organized mass screening events — typically in communities with industrial histories — where workers received chest X-rays that were read by physicians holding NIOSH B-reader certification. B-readers are physicians who have passed a proficiency examination demonstrating competence in classifying chest radiographs for pneumoconiosis using the International Labour Organization classification system.

The B-reader certification is a valid professional credential administered by NIOSH. It confirms that the physician demonstrated proficiency in reading occupational chest films. The certification carries no constraint on the volume of readings the physician performs, the financial relationship between the physician and the entity sponsoring the screenings, or the diagnostic threshold the physician applies in a litigation context versus a clinical context. A B-reader being paid per positive diagnosis by a law firm seeking plaintiffs holds the same credential as one performing independent clinical evaluations.

In 2005, Federal Judge Janis Jack presided over silica multidistrict litigation and ordered detailed scrutiny of the diagnoses underlying approximately 10,000 silicosis claims. Her investigation revealed that the vast majority of diagnoses had been produced by a small number of physicians through litigation-sponsored screening operations. Many of the plaintiffs had been previously diagnosed with asbestosis using the same chest X-rays — the same films had been read as showing asbestosis for one lawsuit and silicosis for another, depending on which litigation was active. Some diagnosed individuals had no awareness they had been diagnosed. One physician had produced over 3,000 diagnoses in a two-year period.

Judge Jack's findings documented what she characterized as a system in which diagnoses were manufactured to support litigation rather than produced through genuine medical evaluation. Independent physicians who re-examined the X-rays found that the overwhelming majority did not support the reported diagnoses. The screening operations had produced diagnostic documents that carried the authority of a credentialed medical opinion while reflecting a process driven by litigation economics rather than clinical assessment.

The B-reader credential confirmed that the physician could read chest X-rays for pneumoconiosis. It did not address the conditions under which that skill was exercised. No mechanism constrained how the credential was deployed — no volume limits, no conflict of interest disclosure requirements, no independent verification of diagnostic accuracy when the physician's output was being used for litigation rather than clinical purposes. The credential was binary: the physician was a certified B-reader, or not. The certification carried the same weight whether the physician produced ten readings a year in an independent clinical context or three thousand readings a year for a law firm paying per diagnosis.

The gap between the credential and its deployment context was structural. Courts accepted diagnoses based on the physician's B-reader certification without a mechanism to evaluate whether the diagnostic context preserved the integrity the certification was supposed to guarantee. The credential certified competency. Competency deployed in a context with financial incentives to diagnose, volume pressure, and no independent accuracy verification produced output that looked identical to competency deployed in a clinical context — because the credential itself was the verification surface, and the credential was valid regardless of context.

Judge Jack's findings triggered widespread scrutiny of litigation-driven medical screening operations. Courts in multiple jurisdictions imposed requirements for independent medical evaluation and excluded diagnoses produced through litigation-sponsored screenings without corroborating clinical evidence. Several states enacted tort reform legislation requiring that asbestos and silica claims be supported by diagnoses meeting specific evidentiary standards, including physician independence requirements and diagnostic methodology criteria. The screening company model that had produced tens of thousands of diagnoses largely collapsed under judicial and legislative pressure, though the claims already filed on the basis of those diagnoses required years of individual case review.